Rafael Hernandez, MD
Family Medicine · Fredericksburg, VANPI 1982667812
Payments from drug & device makers
Across 1,145 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novo Nordisk$2K
- Pfizer$1K
- AstraZeneca$1K
- Amgen$1K
- Lilly USA, LLC$871
- plus $8K from 51 others
What the payments were for
- Food & beverage$17,20798%
- Education$2942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$250
- Repatha$250
- VRAYLAR$229
- BREZTRI$124
- NEXLIZET$123
- NEXLETOL$123
- DEXCOM G7 GSS (161)$117
- DEXCOM STELO GLUCOSE BIOSENSOR$117
- SYMBICORT$110
- FARXIGA$110
- SOLIQUA 100/33$101
How this compares
$17,501 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $49,945 |
| XareltoRivaroxaban | 39 | $34,396 |
| JanuviaSitagliptin Phosphate | 25 | $32,317 |
| AptiomEslicarbazepine Acetate | 13 | $31,806 |
| FarxigaDapagliflozin Propanediol | 37 | $29,604 |
| JardianceEmpagliflozin | 21 | $20,794 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $20,054 |
| OzempicSemaglutide | 16 | $18,706 |
| VraylarCariprazine Hcl | 12 | $16,670 |
| GemtesaVibegron | 24 | $14,772 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $14,314 |
| LinzessLinaclotide | 19 | $14,279 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $13,066 |
| MyrbetriqMirabegron | 16 | $12,097 |
| TradjentaLinagliptin | 15 | $11,592 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet | $390 | $52,37141 claims |
| PfizerEliquis | $1,492 | $49,94548 claims |
| Johnson & JohnsonXarelto | $72 | $34,39639 claims |
| Boehringer IngelheimJardiance, Tradjenta | $634 | $32,38636 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $205 | $31,80613 claims |
| AbbVieVraylar, Linzess | $2,778 | $30,94931 claims |
| AstraZenecaFarxiga | $1,308 | $29,60437 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $694 | $27,38040 claims |
| Novo NordiskOzempic | $1,512 | $18,70616 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $105 | $14,77224 claims |
| Astellas Pharma US IncMyrbetriq | $788 | $12,09716 claims |
| Lilly USA, LLCMounjaro | $871 | $11,19411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Fredericksburg
- Dana BrownFredericksburg$21K
- Julie FloydFredericksburg$20K
- Wilson CookFredericksburg$17K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.